Title:
A CYCLIN-DEPENDENT KINASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/186065
Kind Code:
A1
Abstract:
The present disclosure provides a series of compounds as potent inhibitors of cyclin-dependent kinase (CDK), or pharmaceutically acceptable salts thereof. Corresponding compositions are also provided.
Inventors:
MO LEI (CN)
HUANG JUNKAI (CN)
LI KAI (CN)
HU XIAOHUI (CN)
ZHOU LI (CN)
CUI TAO (CN)
CHEN DONGQIANG (CN)
HUANG JUNKAI (CN)
LI KAI (CN)
HU XIAOHUI (CN)
ZHOU LI (CN)
CUI TAO (CN)
CHEN DONGQIANG (CN)
Application Number:
PCT/CN2023/085372
Publication Date:
October 05, 2023
Filing Date:
March 31, 2023
Export Citation:
Assignee:
TAIZHOU EOC PHARMA CO LTD (CN)
International Classes:
C07D403/14; A61K31/35; A61K31/519; A61K31/52; A61K31/535; A61P35/00; C07D473/34; C07D487/04
Domestic Patent References:
| WO2022206795A1 | 2022-10-06 | |||
| WO2023016477A1 | 2023-02-16 | |||
| WO2023046128A1 | 2023-03-30 | |||
| WO2016160617A2 | 2016-10-06 | |||
| WO2010036380A1 | 2010-04-01 |
Other References:
DATABASE Registry CAS; 23 April 2021 (2021-04-23), ANONYMOUS : "Thieno[2,3-d]pyrimidin-4 -amine, N-[[2-(1H-imi dazol-2-yl)phenyl]m ethyl]-2- (2-pyridinyl)- ", XP093094687, retrieved from STN Database accession no. 2637184-74-6
Attorney, Agent or Firm:
SUNSHINE INTELLECTUAL PROPERTY INTERNATIONAL CO., LTD. (CN)
Download PDF:
Previous Patent: NETWORK CONNECTION METHOD AND APPARATUS, TERMINAL, AND BASE STATION
Next Patent: MOBILE MEDICAL DEVICES
Next Patent: MOBILE MEDICAL DEVICES